Anti-thymocyte globulin for GVHD: one dose does not fit all

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

Toegang tot document

@article{b7f62c2bfc0e46759ba69193f7fdef03,

title = "Anti-thymocyte globulin for GVHD: one dose does not fit all",

keywords = "Antilymphocyte Serum, Graft vs Host Disease, Hematologic Neoplasms, Humans, Neoplasm Recurrence, Local, Unrelated Donors",

author = "Rick Admiraal and Boelens, {Jaap J}",

year = "2020",

month = jul,

doi = "10.1016/S2352-3026(20)30181-2",

language = "English",

volume = "7",

pages = "e505",

journal = "The Lancet. Haematology",

issn = "2352-3026",

publisher = "Lancet Publishing Group",

number = "7",

}

TY - JOUR

T1 - Anti-thymocyte globulin for GVHD

T2 - one dose does not fit all

AU - Admiraal, Rick

AU - Boelens, Jaap J

PY - 2020/7

Y1 - 2020/7

KW - Antilymphocyte Serum

KW - Graft vs Host Disease

KW - Hematologic Neoplasms

KW - Humans

KW - Neoplasm Recurrence, Local

KW - Unrelated Donors

U2 - 10.1016/S2352-3026(20)30181-2

DO - 10.1016/S2352-3026(20)30181-2

M3 - Article

C2 - 32589973

SN - 2352-3026

VL - 7

SP - e505

JO - The Lancet. Haematology

JF - The Lancet. Haematology

IS - 7

ER -